Significant barriers to progress in SCLC include: (1) lack of early detection modalities; (2) limited tumor tissue for study of translation (molecular profiles of DNA, RNA, and / or protein alterations) because diagnostic biopsy specimens are often small and surgical resection is rare in the treatment; (3) rapidly progressive disease with little understanding of the mechanisms of resistance to treatment.